Pharmacological Management of Type 2 Diabetes Mellitus: Rationale for Rational Use of Insulin
- 30 April 2003
- journal article
- review article
- Published by Elsevier in Mayo Clinic Proceedings
- Vol. 78 (4) , 459-467
- https://doi.org/10.4065/78.4.459
Abstract
No abstract availableKeywords
This publication has 58 references indexed in Scilit:
- The Effect of a Thiazolidinedione Drug, Troglitazone, on Glycemia in Patients with Type 2 Diabetes Mellitus Poorly Controlled with Sulfonylurea and Metformin: A Multicenter, Randomized, Double-Blind, Placebo-Controlled TrialAnnals of Internal Medicine, 2001
- NateglinideDrugs, 2000
- PioglitazoneDrugs, 2000
- The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitusJournal of Clinical Investigation, 1999
- Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)The Lancet, 1998
- Troglitazone in Combination With Sulfonylurea Restores Glycemic Control in Patients With Type 2 DiabetesDiabetes Care, 1998
- Morning or Bedtime NPH Insulin Combined With Sulfonylurea in Treatment of NIDDMDiabetes Care, 1992
- Pathogenesis of NIDDM: A Balanced OverviewDiabetes Care, 1992
- Banting lecture 1990. Beta-cells in type II diabetes mellitusDiabetes, 1991
- Intermediate acting insulin given at bedtime: effect on blood glucose concentrations before and after breakfast.BMJ, 1983